Duojia Pan

Active 1995–2024

78
Papers
26,914
Citations
64
h-index
75
i10-index

Citations

Citations per year for Duojia Pan1928: 1 citations1982: 2 citations1995: 13 citations1996: 23 citations1997: 47 citations1998: 70 citations1999: 66 citations2000: 78 citations2001: 81 citations2002: 109 citations2003: 166 citations2004: 174 citations2005: 162 citations2006: 165 citations2007: 136 citations2008: 225 citations2009: 235 citations2010: 356 citations2011: 356 citations2012: 386 citations2013: 395 citations2014: 433 citations2015: 621 citations2016: 516 citations2017: 390 citations2018: 514 citations2019: 1,199 citations2020: 1,237 citations2021: 1,106 citations2022: 962 citations2023: 597 citations2024: 1,046 citations2025: 429 citations2026: 7 citations1929–1981: no citations, so these years are not shown1983–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,098 citing papers, 32.9% of this breakdownChina: 1,849 citing papers, 19.6% of this breakdownUnited Kingdom: 531 citing papers, 5.6% of this breakdownGermany: 478 citing papers, 5.1% of this breakdownJapan: 349 citing papers, 3.7% of this breakdownCanada: 302 citing papers, 3.2% of this breakdownFrance: 273 citing papers, 2.9% of this breakdownItaly: 254 citing papers, 2.7% of this breakdownSouth Korea: 229 citing papers, 2.4% of this breakdownSwitzerland: 199 citing papers, 2.1% of this breakdownAustralia: 195 citing papers, 2.1% of this breakdownSpain: 174 citing papers, 1.8% of this breakdown
0%32.9%Other 15.9%

Fields

  • Biochemistry, Genetics and Molecular Biology73.7%
  • Medicine19.1%
  • Neuroscience2.9%
  • Immunology and Microbiology2.2%
  • Agricultural and Biological Sciences0.6%
  • Engineering0.4%
  • Other1.1%

Topics

  • Hippo pathway signaling and YAP/TAZ17.2%
  • Wnt/β-catenin signaling in development and cancer4.6%
  • PI3K/AKT/mTOR signaling in cancer3.1%
  • Ubiquitin and proteasome pathways2.8%
  • Cellular Mechanics and Interactions2.8%
  • Developmental Biology and Gene Regulation2.7%
  • Other66.8%

Coauthors

All papers

Open in search
  1. The Hippo Signaling Pathway in Development and Disease

    Authors: , - Developmental Cell 2019 cited by 934

  2. Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

    Authors: , , , , , , , - Genes & Development 2012 cited by 1,484

  3. Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals

    Authors: , , , , , , , , , - Cell 2007 cited by 2,450

  4. The Hippo Signaling Pathway in Development and Cancer

    Authors: - Developmental Cell 2010 cited by 2,296

  5. The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP

    Authors: , , , , - Cell 2005 cited by 1,905

  6. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway

    Authors: , , , , , , , , , - Nature Chemical Biology 2016 cited by 298

  7. The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals

    Authors: , , , , , , , , , - Developmental Cell 2010 cited by 817

  8. Control of stem cell renewal and fate by YAP and TAZ

    Authors: , - Nature Reviews Molecular Cell Biology 2023 cited by 143

  9. hippo Encodes a Ste-20 Family Protein Kinase that Restricts Cell Proliferation and Promotes Apoptosis in Conjunction with salvador and warts

    Authors: , , , - Cell 2003 cited by 1,110

  10. The Hippo Pathway in Liver Homeostasis and Pathophysiology

    Authors: , - Annual Review of Pathology Mechanisms of Disease 2020 cited by 252

  11. YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 235

  12. Multiphase coalescence mediates Hippo pathway activation

    Authors: , , , , , , , , , , , , - Cell 2022 cited by 111

  13. Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2

    Authors: , , , , , - Cell 2013 cited by 519

  14. YAP/TAZ drives cell proliferation and tumour growth via a polyamine–eIF5A hypusination–LSD1 axis

    Authors: , , , , , , , - Nature Cell Biology 2022 cited by 101

  15. YAP Controls Endothelial Activation and Vascular Inflammation Through TRAF6

    Authors: , , , , , , , , , - Circulation Research 2018 cited by 253

  16. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis

    Authors: , , , , , , , , , , - Genes & Development 2015 cited by 377

  17. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response

    Authors: , , , , , , , , - Nature Communications 2014 cited by 276

  18. A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Metabolism 2022 cited by 106

  19. Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways

    Authors: , , , , , , , , , , , , - Cell 2009 cited by 712

  20. The TEAD/TEF Family Protein Scalloped Mediates Transcriptional Output of the Hippo Growth-Regulatory Pathway

    Authors: , , , , - Developmental Cell 2008 cited by 649

  21. Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade

    Authors: , , , , , - Developmental Cell 2015 cited by 220

  22. YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis

    Authors: , , , , - Nature Genetics 2022 cited by 86

  23. The Hippo Effector Yorkie Controls Normal Tissue Growth by Antagonizing Scalloped-Mediated Default Repression

    Authors: , , , , , , , , - Developmental Cell 2013 cited by 288

  24. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program

    Authors: , , , , , - Genes & Development 2010 cited by 494